Assessment of PD-L1 expression in circulating tumor cells in patients with breast cancer.

被引：0
|
作者：
Chen, Junqing [1 ]
Chen, Zhanhong [1 ]
Wang, Xiaojia [1 ]
机构：
[1] Zhejiang Canc Hosp, Hangzhou, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e13001
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Assessment of PD-L1 expression on circulating tumor cells (CTCs) and immune cells in peripheral blood of patients with small cell lung cancer (SCLC)
    Papadaki, M. A.
    Kapetanaki, E-E.
    Vorrias, E.
    Mavroudis, D.
    Agelaki, S.
    [J]. ANNALS OF ONCOLOGY, 2021, 32 : S1166 - S1166
  • [32] Dynamic change of PD-L1 expression on circulating tumor cells in advanced breast cancer undergoing PD-1 blockade therapy.
    Wang, Tao
    Zhou, Jinmei
    Zhang, Shaohua
    Bian, Li
    Hu, Zhiyuan
    Jiang, Zefei
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [33] Consistent expression of PD-L1 in tumor microenvironment with peripheral PD-1/PD-L1 in circulating T lymphocytes of operable breast cancer: a diagnostic test
    Keyu Yuan
    Jiangping Wu
    Yanjie Zhao
    Shuzhen Lyu
    Quan Zhou
    Feng Shi
    Yanping Li
    Qingkun Song
    [J]. Diagnostic Pathology, 17
  • [34] Consistent expression of PD-L1 in tumor microenvironment with peripheral PD-1/PD-L1 in circulating T lymphocytes of operable breast cancer: a diagnostic test
    Yuan, Keyu
    Wu, Jiangping
    Zhao, Yanjie
    Lyu, Shuzhen
    Zhou, Quan
    Shi, Feng
    Li, Yanping
    Song, Qingkun
    [J]. DIAGNOSTIC PATHOLOGY, 2022, 17 (01)
  • [35] PD-L1 expression in primary tumor and circulating tumor cells in patients with small cell lung carcinomas
    Ilie, Marius
    Hofman, Veronique
    Long, Elodie
    Butori, Catherine
    Lalvee, Salome
    Selva, Eric
    Venissac, Nicolas
    Mouroux, Jerome
    Marquette, Charles Hugo
    Hofman, Paul
    [J]. CANCER RESEARCH, 2016, 76
  • [36] Correlation of micronuclei formation in circulating stromal cells with their PD-L1 expression and predicts for poorer clinical outcomes in metastatic breast cancer.
    Kasabwala, Dimpal M.
    Cristofanilli, Massimo
    Alpaugh, R. Katherine
    Chumsri, Saranya
    Tang, Cha-Mei
    Lapidus, Rena G.
    Del Priore, Giuseppe
    Chang, Mingjin
    Iwase, Toshiaki
    Ueno, Naoto T.
    Adams, Daniel L.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [37] Expression of PD-L1 on circulating breast cancer cells: Correlation with clinicopathologic data and impact on prognosis
    Jacot, William
    Mazel, Martine
    Mollevi, Caroline
    Pouderoux, Stephane
    D'Hondt, Veronique
    Cayrefourcq, Laure
    Ducteil, Angelique
    Viala, Marie
    Maudelonde, Thierry
    Guiu, Severine
    Alix-Panabieres, Catherine
    [J]. CANCER RESEARCH, 2018, 78 (13)
  • [38] Non-invasive assessment of tumor PD-L1 status with circulating tumor cells
    Ulrich, Bryan C.
    Guibert, Nicolas
    [J]. ANNALS OF TRANSLATIONAL MEDICINE, 2018, 6
  • [39] PD-L1 expression and PD-1/PD-L1 inhibitors in breast cancer
    Monneur, Audrey
    Goncalves, Anthony
    Bertucci, Francois
    [J]. BULLETIN DU CANCER, 2018, 105 (03) : 261 - 272
  • [40] Sequential tracking of PD-L1 expression on circulating tumor cells in NSCLC patients treated with nivolumab
    Akamatsu, Hiroaki
    Koh, Yasuhiro
    Mori, Keita
    Kanai, Kuninobu
    Hayata, Atsushi
    Tokudome, Nahomi
    Higuchi, Masayuki
    Kanbara, Hlsashige
    Akamatsu, Keiichiro
    Nakanishi, Masanori
    Ueda, Hiroki
    Yamamoto, Nobuyuki
    [J]. MOLECULAR CANCER THERAPEUTICS, 2018, 17 (01)
12345